214 related articles for article (PubMed ID: 15761865)
21. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor.
Prawitt D; Enklaar T; Gärtner-Rupprecht B; Spangenberg C; Oswald M; Lausch E; Schmidtke P; Reutzel D; Fees S; Lucito R; Korzon M; Brozek I; Limon J; Housman DE; Pelletier J; Zabel B
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4085-90. PubMed ID: 15743916
[TBL] [Abstract][Full Text] [Related]
22. Global demethylation in loss of imprinting subtype of Wilms tumor.
Ludgate JL; Le Mée G; Fukuzawa R; Rodger EJ; Weeks RJ; Reeve AE; Morison IM
Genes Chromosomes Cancer; 2013 Feb; 52(2):174-84. PubMed ID: 23074036
[TBL] [Abstract][Full Text] [Related]
23. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
[TBL] [Abstract][Full Text] [Related]
24. Role of genomic imprinting in Wilms' tumour and overgrowth disorders.
Reeve AE
Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076
[TBL] [Abstract][Full Text] [Related]
25. Loss of imprinting of IGF2 and H19, loss of heterozygosity of IGF2R and CTCF, and Helicobacter pylori infection in laryngeal squamous cell carcinoma.
Grbesa I; Marinkovic M; Ivkic M; Kruslin B; Novak-Kujundzic R; Pegan B; Bogdanovic O; Bedekovic V; Gall-Troselj K
J Mol Med (Berl); 2008 Sep; 86(9):1057-66. PubMed ID: 18604514
[TBL] [Abstract][Full Text] [Related]
26. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma.
Zhan S; Shapiro DN; Helman LJ
J Clin Invest; 1994 Jul; 94(1):445-8. PubMed ID: 8040287
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity at 7p in Wilms' tumour development.
Powlesland RM; Charles AK; Malik KT; Reynolds PA; Pires S; Boavida M; Brown KW
Br J Cancer; 2000 Jan; 82(2):323-9. PubMed ID: 10646884
[TBL] [Abstract][Full Text] [Related]
29. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
Vu TH; Hoffman A
J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
[TBL] [Abstract][Full Text] [Related]
30. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu TH; Chuyen NV; Li T; Hoffman AR
Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
[TBL] [Abstract][Full Text] [Related]
31. Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer.
Takano Y; Shiota G; Kawasaki H
Oncology; 2000 Sep; 59(3):210-6. PubMed ID: 11053988
[TBL] [Abstract][Full Text] [Related]
32. Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases.
Safford SD; Goyeau D; Freemerman AJ; Bentley R; Everett ML; Grundy PE; Skinner MA
Ann Surg Oncol; 2003 Mar; 10(2):136-43. PubMed ID: 12620908
[TBL] [Abstract][Full Text] [Related]
33. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
34. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.
Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K
Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489
[TBL] [Abstract][Full Text] [Related]
35. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas.
Rainho CA; Kowalski LP; Rogatto SR
Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232
[TBL] [Abstract][Full Text] [Related]
36. Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities.
Haruta M; Arai Y; Sugawara W; Watanabe N; Honda S; Ohshima J; Soejima H; Nakadate H; Okita H; Hata J; Fukuzawa M; Kaneko Y
Genes Chromosomes Cancer; 2008 Aug; 47(8):712-27. PubMed ID: 18464243
[TBL] [Abstract][Full Text] [Related]
37. 16q loss of heterozygosity and microsatellite instability in Wilms' tumor.
Mason JE; Goodfellow PJ; Grundy PE; Skinner MA
J Pediatr Surg; 2000 Jun; 35(6):891-6; discussion 896-7. PubMed ID: 10873032
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
[TBL] [Abstract][Full Text] [Related]
39. Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma.
Wu MS; Wang HP; Lin CC; Sheu JC; Shun CT; Lee WJ; Lin JT
Cancer Lett; 1997 Nov; 120(1):9-14. PubMed ID: 9570380
[TBL] [Abstract][Full Text] [Related]
40. Loss of imprinting of long QT intronic transcript 1 in colorectal cancer.
Tanaka K; Shiota G; Meguro M; Mitsuya K; Oshimura M; Kawasaki H
Oncology; 2001; 60(3):268-73. PubMed ID: 11340379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
